Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ripley Corp SA
SGO:RIPLEY
|
CL |
|
Z
|
Zhuhai Port Co Ltd
SZSE:000507
|
CN |
|
T
|
Telecom Argentina SA
F:TEO
|
AR |
|
Verianos Se
XETRA:VROS
|
DE |
Pharma Equity Group A/S
Other Current Liabilities
Pharma Equity Group A/S
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pharma Equity Group A/S
CSE:PEG
|
Other Current Liabilities
kr1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Other Current Liabilities
kr428.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Other Current Liabilities
kr13.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Other Current Liabilities
kr45.5m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
9%
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Other Current Liabilities
kr27m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Other Current Liabilities
kr2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-8%
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.
See Also
What is Pharma Equity Group A/S's Other Current Liabilities?
Other Current Liabilities
1.5m
DKK
Based on the financial report for Dec 31, 2025, Pharma Equity Group A/S's Other Current Liabilities amounts to 1.5m DKK.
What is Pharma Equity Group A/S's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-31%
Over the last year, the Other Current Liabilities growth was -5%.
